Zdrowie i gospodarka · 14/06/2018

FDA Classifies Brain Trauma Assessment Test into Class II with Special Controls

The US Food and Drug Administration (FDA) is classifying the brain trauma assessment test into Class II, requiring special controls, to ensure its safety and effectiveness. This move aims to reduce regulatory burdens and increase access to innovative devices for patients.